Nu-Med Plus, Inc. Approaches Milestone FDA Application for New Nitric Oxide Medical Device Approval
Innovative Nitric Oxide Delivery Device Company Announces Addition of FDA Advisor SALT LAKE CITY, June 18, 2019 (GLOBE NEWSWIRE) —
Read more
Medical Stocks
RENNOVA HEALTH WELCOMES NEW CHIEF FINANCIAL OFFICER
WEST PALM BEACH, Fla, April 09, 2019 (GLOBE NEWSWIRE) — Rennova Health, Inc. (OTC: RNVA), (OTC: RNVAW), (“Rennova” or the “Company”),
Read more
Todos and Amarantus Announce Completion of LymPro PET 1 Study by Leipzig University for Alzheimer’s Blood Diagnostic LymPro Test 2.0
REHOVOT, Israel and NEW YORK, April 08, 2019 (GLOBE NEWSWIRE) — Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro diagnostics
Read more
UPDATE – RENNOVA HEALTH GIVES FINANCIAL UPDATE ON 2018
WEST PALM BEACH, Fla., Feb. 20, 2019 (GLOBE NEWSWIRE) — Rennova Health, Inc. (OTC: RNVA), (OTC: RNVAW), (“Rennova” or the
Read more
Progressive Care Inc. Announces Best January in Company History
MIAMI, Feb. 20, 2019 (GLOBE NEWSWIRE) — Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced further
Read more
International Stem Cell Corporation Publishes Successful Results in Traumatic Brain Injury
CARLSBAD, Calif., Feb. 13, 2019 (GLOBE NEWSWIRE) — International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) (“ISCO” or “the Company”), a California-based
Read more
IntelGenx Facility Undergoes U.S. FDA Pre-Approval Inspection Related to RIZAPORT® NDA
SAINT LAURENT, Quebec, Jan. 30, 2019 (GLOBE NEWSWIRE) — IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), a leading oral drug delivery company,
Read more
PROCESSA PHARMACEUTICALS ANNOUNCES FIRST PATIENT DOSED IN CLINICAL TRIAL TO EVALUATE THE SAFETY AND TOLERABILITY OF PCS-499 FOR THE TREATMENT OF NECROBIOSIS LIPOIDICA
HANOVER, MD, Jan. 29, 2019 (GLOBE NEWSWIRE) — Processa Pharmaceuticals, Inc. (OTCQB: PCSA), a clinical stage biopharmaceutical company developing products
Read more
YIELD GROWTH Announces Completion of FDA Compliant Evaluation with Human Subjects to Establish an SPF Factor of 31 for Urban Juve’s Sunscreen Formula
VANCOUVER, British Columbia, Jan. 28, 2019 (GLOBE NEWSWIRE) — The Yield Growth Corp. (CSE:BOSS) (C:BOSS) (OTC:BOSQF) (Frankfort: YG3) announces completion of the
Read more
Cannabics Pharmaceuticals and NewCanna Hub Intend to Collaborate to Manufacture and Market Cannabics’ SR Capsules in Colombia
TEL AVIV, Israel and BETHESDA, Maryland, Jan. 24, 2019 /PRNewswire/ — Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its
Read more
IntelGenx Provides Update on Phase 2a Montelukast VersaFilm™ Clinical Trial
Eight Alzheimer’s Disease Patients Randomized to Date with Two Additional Sites Expected SAINT LAURENT, Quebec, Jan. 23, 2019 (GLOBE NEWSWIRE)
Read more
Progressive Care Releases Open Letter to Shareholders
MIAMI, Jan. 17, 2019 (GLOBE NEWSWIRE) — In a release issued under the same headline earlier today by Progressive Care
Read more